key: cord-0839602-fuugy4cx authors: Wang, Ruirui; Pan, Min; Zhang, Xiumei; Fan, Xiaoyun; Han, Mingfeng; Zhao, Fengde; Miao, Manli; Xu, Jing; Guan, Minglong; Deng, Xia; Chen, Xu; Shen, Leilei title: Epidemiological and clinical features of 125 Hospitalized Patients with COVID-19 in Fuyang, Anhui, China date: 2020-04-11 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2020.03.070 sha: c01c8ecce063ec5b15fd9012ca7bca3a06c0dbe3 doc_id: 839602 cord_uid: fuugy4cx OBJECTIVE: To investigate the epidemiological and clinical features of patients with COVID-19 in Anhui province of China. METHOD: In this descriptive study, we obtained epidemiological, demographic, manifestations, laboratory data and radiological findings of patients confirmed by real-time RT-PCR in the NO.2 People’s Hospital of Fuyang City from Jan 20 to Feb 9, 2020. Clinical outcomes were followed up to Feb 18, 2020. RESULTS: Of 125 patients infected SARS-CoV-2, the mean age was 38.76 years (SD, 13.799) and 71(56.8%) were male. Common symptoms include fever [116 (92.8%)], cough [102(81.6%)], and shortness of breath [57(45.6%)]. Lymphocytopenia developed in 48(38.4%) patients. 100(80.0%) patients showed bilateral pneumonia, 26(20.8%) patients showed multiple mottling and ground-glass opacity. All patients were given antiviral therapy. 19(15.2%) patients were transferred to the intensive care unit. By February 18, 47(37.6%) patients were discharged and none of patients died. Among the discharged patients, the median time of length of stay was 14.8 days (SD 4.16). CONCLUSION: In this single-center, retrospective, descriptive study, fever is the most common symptom. Old age, chronic underlying diseases and smoking history may be risk factors to worse condition. Certain laboratory inspection may contribute to the judgment of the severity of illness. In December 2019, there were several cases of pneumonia of unknown cause in Wuhan, Hubei province, China, which seemed to be relevant to a local seafood wholesale market in Wuhan. The initial symptoms of most patients are fever, dry cough, and fatigue, then they developed into dyspnea quickly, even acute respiratory distress syndrome (ARDS) Huang et al.,2020) . The Chinese center for disease control and prevention (CDC) promptly dispatched a team to assist local health authorities in Wuhan to carry out investigations on December 31,2019. The Chinese CDC obtained lower respiratory tract samples, which were called bronchoalveolar lavage fluid, from patients of unknown etiology pneumonia in Wuhan Jinyintan Hospital. By whole-genome sequencing, real-time reverse transcription PCR (RT-PCR) and culture of the virus, we recognized that this is a new coronavirus, which is different from severe acute respiratory syndrome (SARS) and middle east respiratory syndrome (MERS) coronavirus (Zhu et al.,2020) . Several days after, similar patients appeared in other cities of China, most of whom had a history of exposure to Wuhan within 14 days. On Jan 22, Anhui province confirmed first case of Novel Coronavirus Pneumonia (NCP). The number of confirmed cases grew rapidly. Anhui province, J o u r n a l P r e -p r o o f which borders Hubei province, is also a major province for migrant workers, many of whom work in Wuhan and other provinces in Hubei. As Chinese Spring Festival drawing near, 4.3 million people travelled out of Wuhan to other cities in China between 11 January and 23 January (Tian et al.,2020) , a lot of whom were migrant workers and college students returned from Wuhan. It provided a shortcut for the virus spreading. On February 7, 2020, National Health Commission of the People's Republic China temporarily named the pneumonia infected by the new coronavirus as Novel Coronavirus Pneumonia(General Office of National Health Commission,2020). On February 11,2020, World Health Organization (WHO) named it coronavirus disease-19 officially. By February 9, 2020, more than 37,000 patients had been diagnosed nationwide, including 779 patients in Anhui province. And the number of confirmed cases is still rising (figure 1). The situation of outbreak in Anhui province is serious. Nowadays, Wuhan has caught the eyes of most people, there are many studies on patients confirmed COVID-19 in Wuhan. However, the study of epidemiological and clinical characteristics of patients with COVID-19 outside Hubei province, such as Anhui province is still blank. We aim to describe epidemiological, demographic, clinical, laboratory and radiologic features in patients confirmed to have COVID-19 of Fuyang, Anhui province. On the one hand, it can provide a theoretical basis for prevention and treatment of the outbreak. On the other hand, it is a good chance to explore whether there are differences in epidemiological features and clinical outcomes of patients with COVID-19 between Wuhan and city outside Hubei province. As of March 20, 2020, the cumulative number of people diagnosed with COVID-19 in China was more than 81416, while the cumulative number of cured cases was 72386. Through the efforts of the whole country and people in China, the situation is basically stable. Despite a phased victory in the fight against the outbreak of COVID-19 in China, the situation outside China has become serious, more than 160 countries in six continents had reported cases of COVID-19. It is frightening that the number of confirmed cases outside China continued to rise, with a cumulative total of more than 200,000, of which Italy, Spanish, Germany and the United States of America were seriously affected(World Health Organization,2020). At present, COVID-19 is not only a matter of China, it has become a threat to the health of people around the world. Through this study, it can bring some experience of diagnosis and treatment of COVID-19 to medical practitioners in various countries around the world, in order to strive to win this war without gunpowder as soon as possible. Patients from Jan 20 to Feb 9, 2020, who were diagnosed with COVID-19 at the NO.2 People's Hospital of Fuyang City were enrolled in this study. These patients were confirmed by a positive result for real-time RT-PCR in the respiratory tract samples. We sought the consent of the patients or their authorized clients orally to conduct this study. Epidemiological, demographic, clinical manifestations, laboratory results and chest computed J o u r n a l P r e -p r o o f tomography (CT) findings, treatment and clinical outcomes of these patients were obtained from electronic medical records. In order to ascertain some incomplete data, such as epidemiological data, we obtained it through communicating with patients directly. The laboratory results and chest CT findings of the patients were acquired on the day of admission. The clinical outcomes of the patients were followed up to Feb 18, 2020. In this study, we provided respiratory support for critically ill patients according to the criteria of the treatment protocol(version 5)(General Office of National Health Commission, General Office of National Administration of Traditional Chinese Medicine,2020). High flow nasal catheter oxygen therapy or non-invasive ventilation is feasible when respiratory distress and (or) hypoxemia cannot be alleviated after receiving standard oxygen therapy. If the condition cannot be improved or even deteriorated in a short period of time (1-2 hours), tracheal intubation or invasive ventilation should be carried out in time. The date of onset was defined as the date when the patients had clinical symptoms. The date of admission was defined as the date when patients' s first visit to this hospital after the onset of illness. The date of diagnosis was defined as the date when the nucleic acid test results were obtained. Acute respiratory distress syndrome (ARDS) is defined according to the Berlin definition: a. within 1 week of a known clinical insult or new or worsening respiratory symptoms; b. bilateral opacities-not fully explained by effusions, lobar/lung collapse, or nodules; c. respiratory failure not fully explained by cardiac failure or fluid overload need objective assessment (eg, echocardiography) to exclude hydrostatic edema if no risk factor present; d. J o u r n a l P r e -p r o o f patients were classified as mild (200 mmHg